Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-256 tumor-bearing rat model using free intratumoral drug concentrations-Reference-Cited by-同舟云学术

Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-256 tumor-bearing rat model using free intratumoral drug concentrations

Published:2017-01 Issue: Volume:97 Page:70-78
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Pigatto Maiara Cássia,Roman Renatha Menti,Carrara Letizia,Buffon Andréia,Magni Paolo,Dalla Costa Teresa

Funder

National Counsel of Technological and Scientific Development (CNPq/Brazil)

CAPES Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Population pharmacokinetic/pharmacodynamic modelling in oncology: a tool for predicting clinical response;Bender;Br. J. Clin. Pharmacol.,2015

2. Lei 11794/08: Procedimentos para Uso Científico de Animais;Brazil,2008

3. Ministério da Ciência, Tecnologia e Inovação Conselho Nacional de Controle de Experimentação Animal – CONCEA;Brazil,2013

4. Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice;Bueno;Eur. J. Cancer,2008

5. A model based analysis of IPEC dosing of paclitaxel in rats;Colin;Pharm. Res.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic–Pharmacodynamic Analysis of pH-Responsive Doxorubicin-Releasing Micelles with Anticancer Activity;Molecular Pharmaceutics;2024-05-27

2. Evaluation of anticancer effect of micelle-encapsulated doxorubicin using gamma-distributed delay model;Journal of Drug Delivery Science and Technology;2024-01

3. Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule;Cancer Chemotherapy and Pharmacology;2023-12-20

4. Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation;J MED CHEM;2022

5. Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation;Journal of Medicinal Chemistry;2022-07-05